• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

New probiotic treatment for obesity and diabetes [PreClinical]

byCorinne FoleyandJessica Lau
February 10, 2017
in Chronic Disease, Endocrinology, Preclinical, Public Health
Reading Time: 3 mins read
Bariatric surgery linked to decreased all-cause mortality
Share on FacebookShare on TwitterShare on LinkedIn

1. Administering various formulations of the Akkermansia (A.) muciniphila bacterium to mice resulted in improved metabolism and decreased weight gain.

2. A. muciniphila decreased body weight through various mechanisms and was found to be well tolerated in humans.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Although A. muciniphila is normally one of the most abundant bacteria strains in the intestine, levels of this strain are decreased in obese and diabetic patients. In contrast, increased levels have been found to improve cardiovascular health. Given this background, the goals of this study were to determine the specific mechanism of action of this bacterium as well as to improve its therapeutic applicability.

Mice were placed on a high fat diet and then administered either pasteurized or unpasteurized forms of the bacterium. Both groups were found to have a significant decrease in fat mass gain compared to animals without treatment. The treated mice were also found to have a higher glucose tolerance, lower insulin resistance, and lower energy absorption. In addition, this bacterium decreased the expression of a gene known to be involved in the development of atherosclerosis and insulin resistance. The researchers found that A. muciniphila exerted its effects through the TLR2 receptor, leading to improved gut barrier function through the regulation of tight-junction proteins.

Clinical studies have begun to test the safety and efficacy of probiotics containing this bacterium in obese patients. So far, the formulations have been found to be safe to administer with few to no side effects. As more subjects are being recruited for the study, the efficacy of this bacterium on weight loss and overall health will be assessed.

RELATED REPORTS

ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice

Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity

Click to read the study in Nature Medicine

Relevant Reading: Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

FDA approvedFor obesity: Foundayo (orforglipron), Apr 1, 2026→

In-Depth [animal and human study]: First, mice were fed a high fat diet and administered A. muciniphila grown on a mucus-based medium, a synthetic medium more compatible for human administration, or pasteurized for 30 minutes at 72oC. The mice given the pasteurized bacteria had the largest decrease in body weight gain (p<0.001). Due to the greater efficacy of the pasteurized bacteria, this formulation was used in subsequent experiments. The mice given pasteurized bacteria demonstrated lower insulin resistance and decreased plasma glucose levels (p<0.01). In addition, they excreted more calories in their feces (p< 0.05), indicating lower energy absorption. Mice treated with the pasteurized bacteria did not show the increase in Fmo3 expression induced by a high fat diet (p<0.05), potentially leading to the protection of these mice against atherosclerosis and insulin resistance.

The researchers then wanted to determine the mechanism of action through which this bacterium exerted its effects in the intestine. Through genomic and proteomic analyses, Amuc_100 was found to be the most abundant outer membrane protein in A. muciniphila. This protein was then introduced to E. coli and was found to signal through the TLR2 receptor. In mice, administration of Amuc_100 led to the correction of high fat diet-induced hypercholesterolemia (p< 0.05), as well as the increased expression of genes encoding tight-junction proteins that maintain gut barrier function.

Currently, clinical trials of probiotics containing A. muciniphila are underway to evaluate their therapeutic safety and efficacy in obese individuals. Preliminary data included in this study showed that when individuals were treated with different doses of either live or pasteurized bacteria, both groups tolerated the treatment well.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: diabetesobesity
Previous Post

Potential therapeutic target discovered for triple negative breast cancer [PreClinical]

Next Post

Intensive blood pressure control not linked with mobility/gait speed in elderly adults

RelatedReports

A collection of pharmaceutical items including a blister pack of tablets, a pen-like device, and several blank labels or strips, suggesting medication for obesity management.
2MM Trial Briefs

ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice

November 17, 2026
Knee osteoarthritis collage: a calm older man with a gray beard, a knee joint inset with teal cartilage and a knee brace
Endocrinology

Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity

November 17, 2026
Obesity measurement collage: a bathroom scale with a blank dial, a loose cloth measuring tape, an apple and a pear
Chronic Disease

Obesity associated with higher early-onset cancer risk among young Korean adults

November 13, 2026
A variety of pharmaceutical items including a vial, capsule, molecule model, pill blister pack, petri dish with a pipette, and a graph, symbolizing drug development.
Pharma Roundup

2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review

November 9, 2026
Next Post
Blood pressure variability associated with cardiovascular disease and mortality

Intensive blood pressure control not linked with mobility/gait speed in elderly adults

Inhibition of the immunoproteasome may improve graft acceptance [PreClinical]

Ultrasound-guided microwave ablation may be effective in severe secondary hyperparathyroidism

Ultrasound-guided microwave ablation may be effective in severe secondary hyperparathyroidism

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind November 16, 2026
  • ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice
  • Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.